Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to Meta-Analysis, 1st edn. Wiley

Clayton AH, Lasser R, Parikh SV et al (2023) Zuranolone for the treatment of adults with major depressive disorder: A randomized, Placebo-Controlled phase 3 trial. AJP 180:676–684. https://doi.org/10.1176/appi.ajp.20220459

Article  Google Scholar 

Deligiannidis KM, Meltzer-Brody S, Maximos B et al (2023) Zuranolone for the treatment of postpartum depression. AJP 180:668–675. https://doi.org/10.1176/appi.ajp.20220785

Article  Google Scholar 

Fayoud AM, Orebi HA, Elshnoudy IA et al (2024) The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis. Psychopharmacology 241:1299–1317. https://doi.org/10.1007/s00213-024-06611-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higgins JPT (2019) Chap. 23: including variants on randomized trials. In: Li T, Eldridge S (eds) Cochrane handbook for systematic reviews of interventions, 2nd edn. Wiley

Higgins JPT, Li T, Deeks JJ (2019) Chap. 6: choosing effect measures and computing estimates of effect. Cochrane handbook for systematic reviews of interventions, 2nd edn. Wiley, Hoboken, New Jersey, pp 375–402

Chapter  Google Scholar